Skip to main content
Figure 5 | BMC Complementary and Alternative Medicine

Figure 5

From: Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells

Figure 5

The effects of Scutellaria baicalensis extract (50 μg/ml) and BCNU on glioma cell viability in BCNU-resistant and low passage cell lines. (A) Glioma cell lines from primary and recurrent tumors (ME/MER; DI/DIR) selected for resistance to 10 μg/ml BCNU (designated "Drug") were treated with either 50 μg/ml of S. baicalensis extract alone (Scut.), 2.5 μg/ml of BCNU alone, or a combination of the S. baicalensis extract and BCNU (Scut. + BCNU). (B) Low passage cells from tumor 00WA were treated with either 50 μg/ml of S. baicalensis extract alone (Scut.), 5 μg/ml of BCNU alone, or a combination of the S. baicalensis extract and BCNU (Scut. + BCNU). The percentage of viable cells following 3 consecutive days of treatment was assessed using a trypan blue exclusion assay. Results are normalized to the control (untreated) cells and data is the mean ± SD for 2 replicates.

Back to article page